melphalan

The drug is used to treat multiple myeloma, late-stage ovarian carcinoma, neuroblastoma (stage IV in children), as well as localized melanoma and soft tissue sarcoma of the limbs (via regional perfusion).

Form: powder for injection solution

ATC: L01AA03

Manufacturer: GlaxoSmithKline Manufacturing S.p.A. (manufacturing, primary and secondary packaging, quality control, batch release of powder and secondary packaging, quality control and batch release of solvent)

The drug is used for the treatment of multiple myeloma, late-stage ovarian adenocarcinoma, breast cancer, and polycythemia vera.

Form: tablets, film-coated

ATC: L01AA03

Manufacturer: Exella GmbH & Co. KG